|  Help  |  About  |  Contact Us

Publication : Sequential engagement of FcεRI on Mast Cells and Basophil Histamine H(4) Receptor and FcεRI in Allergic Rhinitis.

First Author  Shiraishi Y Year  2013
Journal  J Immunol Volume  190
Issue  2 Pages  539-48
PubMed ID  23241885 Mgi Jnum  J:191727
Mgi Id  MGI:5462483 Doi  10.4049/jimmunol.1202049
Citation  Shiraishi Y, et al. (2013) Sequential Engagement of Fc{varepsilon}RI on Mast Cells and Basophil Histamine H4 Receptor and Fc{varepsilon}RI in Allergic Rhinitis. J Immunol 190(2):539-48
abstractText  Histamine H(4) receptor (H(4)R)-deficient mice (H(4)R(-/-)), H(4)R antagonist-treated wild-type (WT) mice, and WT mice depleted of basophils failed to develop early (EPR) or late phase (LPR) nasal responses following allergen sensitization and challenge. Basophil transfer from WT but not H(4)R(-/-) mice restored the EPR and LPR in H(4)R(-/-) mice. Following passive sensitization with OVA-specific IgE, FcepsilonRI(-/-) recipients of WT basophils plus OVA and histamine developed an EPR and LPR. OVA-IgE passively sensitized FcepsilonRI(-/-) recipients of H(4)R(-/-) basophils and OVA and histamine challenge failed to develop an EPR or LPR, and basophils were not detected in nasal tissue. In contrast, recipients of basophils from IL-13(-/-) and IL-4(-/-)/IL-13(-/-) mice developed an EPR but not an LPR. These results demonstrate the development of allergic rhinitis proceeded in two distinct stages: histamine release from FcepsilonRI-activated mast cells, followed by histamine-mediated recruitment of H(4)R-expressing basophils to the nasal cavity and activation through FcepsilonRI.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

0 Expression